Attenua, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.attenua.com
A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Attenua, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT03622216
- Locations
- 🇺🇸
BioSolutions Clinical Research Center, La Mesa, California, United States
🇺🇸Colorado Allergy and Asthma Center, Denver, Colorado, United States
🇺🇸Allergy & Asthma Associates of Southern California, Mission Viejo, California, United States
© Copyright 2025. All Rights Reserved by MedPath